ALOGLIPTIN AND PIOGLITAZONE

ALOGLIPTIN AND PIOGLITAZONE was reported 249 times

ALOGLIPTIN AND PIOGLITAZONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLADDER TRANSITIONAL CELL CARCINOMA STAGE II 2 0.0435
1 BLADDER TRANSITIONAL CELL CARCINOMA STAGE III 1 0.0256
2 GENITAL ABSCESS 2 0.0050
3 PENILE OEDEMA 1 0.0031
4 SKIN FIBROSIS 1 0.0021
5 GASTROINTESTINAL POLYP HAEMORRHAGE 1 0.0017
6 GENITAL INFECTION FUNGAL 1 0.0012
7 BLOOD PH DECREASED 2 0.0012
8 PERIRECTAL ABSCESS 1 0.0009
9 CONTRAINDICATION TO MEDICAL TREATMENT 1 0.0007
10 GLYCOSYLATED HAEMOGLOBIN DECREASED 1 0.0006
11 WOUND INFECTION STAPHYLOCOCCAL 1 0.0006
12 SPONDYLOLISTHESIS 1 0.0006
13 ERYTHEMA NODOSUM 2 0.0006
14 ABDOMINAL WALL HAEMATOMA 1 0.0005
15 HEPATIC PAIN 2 0.0005
16 BLOOD LOSS ANAEMIA 1 0.0004
17 PENIS DISORDER 1 0.0004
18 ANAL ABSCESS 2 0.0004
19 MACULAR OEDEMA 2 0.0004
20 URINE ODOUR ABNORMAL 2 0.0003
21 METABOLIC ENCEPHALOPATHY 1 0.0003
22 NECROTISING FASCIITIS 1 0.0003
23 RENAL PAIN 3 0.0003
24 EPIGASTRIC DISCOMFORT 1 0.0003
25 GENERALISED OEDEMA 3 0.0002
26 EUGLYCAEMIC DIABETIC KETOACIDOSIS 1 0.0002
27 BLOOD GLUCOSE ABNORMAL 4 0.0002
28 HUNGER 3 0.0002
29 DIABETIC KETOACIDOSIS 5 0.0002
30 PROTEIN URINE PRESENT 1 0.0002
31 GLYCOSYLATED HAEMOGLOBIN INCREASED 5 0.0002
32 VULVOVAGINAL PRURITUS 1 0.0002
33 TOE AMPUTATION 1 0.0002
34 PANCREATITIS 10 0.0002
35 BLOOD GLUCOSE FLUCTUATION 2 0.0002
36 DRUG LEVEL INCREASED 3 0.0002
37 NECROSIS 1 0.0002
38 PANCREATITIS ACUTE 4 0.0002
39 FACE OEDEMA 3 0.0002
40 METASTASES TO LUNG 2 0.0002
41 GANGRENE 1 0.0002
42 BURSITIS 2 0.0002
43 VULVOVAGINAL BURNING SENSATION 1 0.0002
44 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
45 ANGINA UNSTABLE 1 0.0002
46 ARTHROPOD BITE 1 0.0001
47 LIPASE INCREASED 1 0.0001
48 ATRIOVENTRICULAR BLOCK 1 0.0001
49 ATRIAL FLUTTER 1 0.0001
50 LACTIC ACIDOSIS 4 0.0001
51 HICCUPS 1 0.0001
52 BLOOD UREA INCREASED 2 0.0001
53 PERICARDITIS 2 0.0001
54 HAEMATURIA 4 0.0001
55 MUSCLE STRAIN 1 0.0001
56 OEDEMA 6 0.0001
57 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
58 NEPHROPATHY 1 0.0001
59 LIVER FUNCTION TEST ABNORMAL 3 0.0001
60 FLUID RETENTION 5 0.0001
61 TOOTH ABSCESS 1 0.0001
62 POOR VENOUS ACCESS 1 0.0001
63 WEIGHT FLUCTUATION 1 0.0001
64 WEIGHT INCREASED 21 0.0001
65 BREAST PAIN 1 0.0001
66 BODY HEIGHT DECREASED 1 0.0001
67 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
68 TENDON RUPTURE 1 0.0001
69 IMMUNE SYSTEM DISORDER 1 0.0001
70 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
71 HAIR TEXTURE ABNORMAL 1 0.0001
72 JAUNDICE 2 0.0001
73 GASTROENTERITIS 1 0.0001
74 LABORATORY TEST ABNORMAL 2 0.0001
75 DYSGEUSIA 5 0.0001
76 VISION BLURRED 9 0.0001
77 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
78 MUSCULOSKELETAL CHEST PAIN 1 0.0001
79 LIP SWELLING 2 0.0001
80 CANDIDA INFECTION 1 0.0001
81 CIRCULATORY COLLAPSE 1 0.0001
82 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
83 HEAD DISCOMFORT 1 0.0001
84 GALLBLADDER DISORDER 1 0.0001
85 OSTEOMYELITIS 1 0.0001
86 THINKING ABNORMAL 1 0.0001
87 MIDDLE INSOMNIA 1 0.0001
88 SWELLING 5 0.0001
89 HOT FLUSH 4 0.0001
90 BLOOD GLUCOSE INCREASED 10 0.0001
91 GASTRIC ULCER 1 0.0001
92 INCREASED APPETITE 1 0.0001
93 LOWER LIMB FRACTURE 1 0.0001
94 ERUCTATION 1 0.0001
95 JOINT SWELLING 6 0.0000
96 PRODUCT PHYSICAL ISSUE 1 0.0000
97 THERAPEUTIC RESPONSE DECREASED 3 0.0000
98 DERMATITIS 1 0.0000
99 MYALGIA 8 0.0000
100 POOR QUALITY SLEEP 1 0.0000
101 PRURITUS GENERALISED 1 0.0000
102 BLOOD CREATININE INCREASED 3 0.0000
103 CARDIAC DISORDER 4 0.0000
104 LIVER INJURY 1 0.0000
105 HAEMATEMESIS 1 0.0000
106 THERAPY CESSATION 2 0.0000
107 PERIPHERAL SWELLING 6 0.0000
108 SKIN ULCER 1 0.0000
109 DIPLOPIA 1 0.0000
110 NERVOUSNESS 2 0.0000
111 JOINT STIFFNESS 1 0.0000
112 ANHEDONIA 1 0.0000
113 CARDIAC FAILURE 3 0.0000
114 CARDIAC FAILURE CONGESTIVE 3 0.0000
115 BLOOD BILIRUBIN INCREASED 1 0.0000
116 DRY MOUTH 3 0.0000
117 DIVERTICULITIS 1 0.0000
118 DYSSTASIA 1 0.0000
119 ABDOMINAL PAIN UPPER 7 0.0000
120 PSYCHOTIC DISORDER 1 0.0000
121 IRRITABILITY 2 0.0000
122 HEPATIC FAILURE 1 0.0000
123 OEDEMA PERIPHERAL 4 0.0000
124 ACUTE KIDNEY INJURY 5 0.0000
125 DRUG ADMINISTRATION ERROR 1 0.0000
126 LIMB DISCOMFORT 1 0.0000
127 BONE DENSITY DECREASED 1 0.0000
128 RHINORRHOEA 2 0.0000
129 VISUAL ACUITY REDUCED 1 0.0000
130 SINUSITIS 3 0.0000
131 GASTRIC DISORDER 1 0.0000
132 ABDOMINAL DISTENSION 3 0.0000
133 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
134 DRUG EFFECT INCOMPLETE 1 0.0000
135 DYSURIA 1 0.0000
136 PRODUCT USE ISSUE 5 0.0000
137 DYSPNOEA EXERTIONAL 1 0.0000
138 UNEVALUABLE EVENT 2 0.0000
139 COLITIS 1 0.0000
140 RASH 11 0.0000
141 DRUG INTERACTION 4 0.0000
142 DYSKINESIA 1 0.0000
143 LUNG NEOPLASM MALIGNANT 1 0.0000
144 POLLAKIURIA 1 0.0000
145 URTICARIA 4 0.0000
146 HYPERTENSION 5 0.0000
147 RECTAL HAEMORRHAGE 1 0.0000
148 HYPOACUSIS 1 0.0000
149 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
150 GASTROINTESTINAL DISORDER 2 0.0000
151 THROAT IRRITATION 1 0.0000
152 SKIN IRRITATION 1 0.0000
153 TINNITUS 1 0.0000
154 MIGRAINE 2 0.0000
155 BLOOD GLUCOSE DECREASED 1 0.0000
156 DYSPEPSIA 2 0.0000
157 ARTHRALGIA 8 0.0000
158 INSOMNIA 5 0.0000
159 DISTURBANCE IN ATTENTION 1 0.0000
160 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
161 PANCYTOPENIA 1 0.0000
162 BLISTER 1 0.0000
163 OXYGEN SATURATION DECREASED 1 0.0000
164 RHEUMATOID ARTHRITIS 2 0.0000
165 MUSCULAR WEAKNESS 2 0.0000
166 NASAL CONGESTION 1 0.0000
167 NO ADVERSE EVENT 3 0.0000
168 EMOTIONAL DISTRESS 2 0.0000
169 DISCOMFORT 1 0.0000
170 CHEST PAIN 3 0.0000
171 AMNESIA 1 0.0000
172 SWELLING FACE 1 0.0000
173 INFUSION RELATED REACTION 1 0.0000
174 DEHYDRATION 2 0.0000
175 NEOPLASM MALIGNANT 1 0.0000
176 HEADACHE 9 0.0000
177 INJURY 1 0.0000
178 FATIGUE 11 0.0000
179 RESPIRATORY FAILURE 1 0.0000
180 PAIN IN EXTREMITY 4 0.0000
181 BRONCHITIS 1 0.0000
182 EPISTAXIS 1 0.0000
183 CHRONIC KIDNEY DISEASE 1 0.0000
184 DIABETES MELLITUS 1 0.0000
185 BACK PAIN 3 0.0000
186 VOMITING 6 0.0000
187 INJECTION SITE BRUISING 1 0.0000
188 INFLUENZA LIKE ILLNESS 1 0.0000
189 DRUG DOSE OMISSION 2 0.0000
190 DRUG ABUSE 1 0.0000
191 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
192 SKIN EXFOLIATION 1 0.0000
193 BALANCE DISORDER 1 0.0000
194 PAIN 7 0.0000
195 DEVICE ISSUE 1 0.0000
196 ADVERSE DRUG REACTION 1 0.0000
197 ADVERSE EVENT 1 0.0000
198 OROPHARYNGEAL PAIN 1 0.0000
199 WEIGHT DECREASED 3 0.0000
200 ASTHENIA 4 0.0000
201 ANXIETY 3 0.0000
202 GAIT DISTURBANCE 2 0.0000
203 ATRIAL FIBRILLATION 1 0.0000
204 ALOPECIA 2 0.0000
205 NAUSEA 8 0.0000
206 DIZZINESS 5 0.0000
207 HYPOTENSION 2 0.0000
208 HAEMOGLOBIN DECREASED 1 0.0000
209 ILLNESS 1 0.0000
210 MALAISE 4 0.0000
211 FALL 3 0.0000
212 ASTHMA 1 0.0000
213 SEIZURE 1 0.0000
214 ABDOMINAL PAIN 2 0.0000
215 FEELING ABNORMAL 2 0.0000
216 DRUG INEFFECTIVE 11 0.0000
217 PRURITUS 3 0.0000
218 DIARRHOEA 5 0.0000
219 PSORIASIS 1 0.0000
220 RENAL FAILURE 1 0.0000
221 PRODUCT QUALITY ISSUE 1 0.0000
222 MEMORY IMPAIRMENT 1 0.0000
223 PARAESTHESIA 1 0.0000
224 CONFUSIONAL STATE 1 0.0000
225 PNEUMONIA 2 0.0000
226 ABDOMINAL DISCOMFORT 1 0.0000
227 CEREBROVASCULAR ACCIDENT 1 0.0000
228 URINARY TRACT INFECTION 1 0.0000
229 MYOCARDIAL INFARCTION 1 0.0000
230 HYPERSENSITIVITY 1 0.0000
231 DYSPNOEA 3 0.0000
232 ANAEMIA 1 0.0000
233 SOMNOLENCE 1 0.0000
234 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
235 ERYTHEMA 1 0.0000
236 DEPRESSION 1 0.0000
237 DECREASED APPETITE 1 0.0000
238 COUGH 1 0.0000
239 DEATH 3 0.0000
240 CONDITION AGGRAVATED 1 0.0000
241 INJECTION SITE PAIN 1 0.0000
242 OFF LABEL USE 1 0.0000